Silver, R T <br/><br/>
An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: developed for the American Society of Hematology.  [electronic resource] 

 -  Blood  Sep 1999 
 - 1517-36 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>0006-4971 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Bone Marrow Transplantation<br/>Busulfan--adverse effects<br/>Combined Modality Therapy<br/>Evidence-Based Medicine<br/>Humans<br/>Hydroxyurea--adverse effects<br/>Interferon-alpha--adverse effects<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--therapy<br/>Transplantation, Homologous